Literature DB >> 308504

Factors affecting antimicrobial agents in an anaerobic abscess.

F P Tally.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 308504     DOI： 10.1093/jac/4.4.299

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Brain abscess due to Wolinella recta and Streptococcus intermedius.

Authors:  T J Marrie; E Kerr
Journal:  Can J Infect Dis       Date:  1990

Review 2.  Susceptibility testing of anaerobic bacteria.

Authors:  S M Finegold
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Increased production of beta-lactamase under anaerobic conditions in some strains of Escherichia coli.

Authors:  A Rashtchian; R Nouravarsani; G R Miller; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

4.  Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.

Authors:  J Fernandez; J F Barrett; L Licata; D Amaratunga; M Frosco
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 5.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 6.  Clinical relevance of antimicrobial susceptibility testing.

Authors:  S M Finegold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

7.  In vitro activity of LY127935.

Authors:  M Barza; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

Review 8.  Pyogenic arthritis of native joints due to Bacteroides fragilis: Case report and review of the literature.

Authors:  Joan M Nolla; Oscar Murillo; Javier Narvaez; Carmen Gómez Vaquero; Jaime Lora-Tamayo; Salvador Pedrero; Javier Cabo; Javier Ariza
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.